Recombinant Human THSD7A Protein，His

THSD7A, or Thrombospondin Type-1 Domain-Containing Protein 7A, is a member of the thrombospondin-related protein family that has garnered attention in recent years due to its implicated role in various biological processes, including cell adhesion, migration, and angiogenesis. The protein is particularly significant in the context of several diseases, including cancer, where it may facilitate tumor progression and metastasis. Research has shown that THSD7A acts as a potential biomarker for specific cancers, especially in cancer diagnosis and prognosis, making it a focal point for therapeutic strategies. Additionally, its expression patterns have been linked to various physiological conditions and diseases, pointing to its potential as a target for drug development. Studies also delve into the structural aspects of the THSD7A protein, emphasizing its unique domains and their functional implications in cellular activities. Given its multifaceted roles, the recombinant expression of THSD7A provides a valuable tool for understanding its function and interactions at the molecular level, paving the way for novel therapeutic interventions in diseases where THSD7A is involved. Expanding our knowledge of THSD7A through various research methodologies, including protein assays and in vivo studies, is crucial for elucidating the therapeutic potential and clinical relevance of this protein in modern medicine.